Optical Drug Delivery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
226
NCT04910100
Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 15, 2021
Completion: Apr 29, 2022
Loading map...